APO Research
Talk to an analyst

APO RESEARCH · REPORT

Alpha Synuclein

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Alpha Synuclein Market Outlook and Growth Opportunities 2026

19 December 2025196 pages

Choose your research edition.

Industry ResearchAlpha Synuclein Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Alpha Synuclein Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Alpha Synuclein Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Alpha Synuclein Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Alpha Synuclein Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Alpha Synuclein market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Alpha Synuclein is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Alpha Synuclein is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Alpha Synuclein is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Alpha Synuclein market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Alpha Synuclein market include Biogen Inc, reMYND NV, QR Pharma Inc, Prothena Corp Plc, nLife Therapeutics SL, Neuropore Therapies Inc, MedImmune LLC, ICB International Inc and H. Lundbeck A/S, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Alpha Synuclein market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Alpha Synuclein and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Alpha Synuclein sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Alpha Synuclein market size, projected growth trends, production technologies, key applications, and end-use industries.

Alpha Synuclein Segment by Company

Biogen Inc

reMYND NV

QR Pharma Inc

Prothena Corp Plc

nLife Therapeutics SL

Neuropore Therapies Inc

MedImmune LLC

ICB International Inc

H. Lundbeck A/S

Genmab A/S

Evotec AG

BioArctic AB

AFFiRiS AG

AC Immune SA

Alpha Synuclein Segment by Type

DPC-003

BIIB-054

BAN-0805

AV-1950R

AV-1947D

Others

Alpha Synuclein Segment by Application

Multiple System Atrophy

Lewy Body Dementia

Neurodegenerateive Disease

Others

Alpha Synuclein Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Alpha Synuclein status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Alpha Synuclein market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Alpha Synuclein significant trends, drivers, influence factors in global and regions.

6. To analyze Alpha Synuclein competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alpha Synuclein market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Alpha Synuclein and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alpha Synuclein.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Alpha Synuclein market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Alpha Synuclein industry.

Chapter 3: Detailed analysis of Alpha Synuclein manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Alpha Synuclein in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Alpha Synuclein in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Alpha Synuclein Industry Trends Table 2. Alpha Synuclein Industry Drivers Table 3. Alpha Synuclein Industry Opportunities and Challenges Table 4. Alpha Synuclein Industry Restraints Table 5. Global Alpha Synuclein Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Alpha Synuclein Revenue Share by Company (2021-2026) Table 7. Global Alpha Synuclein Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Alpha Synuclein Sales Volume Share by Company (2021-2026) Table 9. Global Alpha Synuclein Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Alpha Synuclein Company Ranking, (2024-2026) & (USD Million) Table 11. Global Alpha Synuclein Key Company Manufacturing Base & Headquarters Table 12. Global Alpha Synuclein Company, Product Type & Application Table 13. Global Alpha Synuclein Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Alpha Synuclein by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of DPC-003 Table 18. Significant Companies of BIIB-054 Table 19. Significant Companies of BAN-0805 Table 20. Significant Companies of AV-1950R Table 21. Significant Companies of AV-1947D Table 22. Significant Companies of Others Table 23. Global Alpha Synuclein Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Alpha Synuclein Sales Volume by Type (2021-2026) & (K Units) Table 25. Global Alpha Synuclein Sales Volume by Type (2027-2032) & (K Units) Table 26. Global Alpha Synuclein Sales Volume Share by Type (2021-2026) Table 27. Global Alpha Synuclein Sales Volume Share by Type (2027-2032) Table 28. Global Alpha Synuclein Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Alpha Synuclein Sales Value by Type (2021-2026) & (US$ Million) Table 30. Global Alpha Synuclein Sales Value by Type (2027-2032) & (US$ Million) Table 31. Global Alpha Synuclein Sales Value Share by Type (2021-2026) Table 32. Global Alpha Synuclein Sales Value Share by Type (2027-2032) Table 33. Significant Companies of Multiple System Atrophy Table 34. Significant Companies of Lewy Body Dementia Table 35. Significant Companies of Neurodegenerateive Disease Table 36. Significant Companies of Others Table 37. Global Alpha Synuclein Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Alpha Synuclein Sales Volume by Application (2021-2026) & (K Units) Table 39. Global Alpha Synuclein Sales Volume by Application (2027-2032) & (K Units) Table 40. Global Alpha Synuclein Sales Volume Share by Application (2021-2026) Table 41. Global Alpha Synuclein Sales Volume Share by Application (2027-2032) Table 42. Global Alpha Synuclein Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 43. Global Alpha Synuclein Sales Value by Application (2021-2026) & (US$ Million) Table 44. Global Alpha Synuclein Sales Value by Application (2027-2032) & (US$ Million) Table 45. Global Alpha Synuclein Sales Value Share by Application (2021-2026) Table 46. Global Alpha Synuclein Sales Value Share by Application (2027-2032) Table 47. Global Alpha Synuclein Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 48. Global Alpha Synuclein Sales by Region (2021-2026) & (K Units) Table 49. Global Alpha Synuclein Sales Market Share by Region (2021-2026) Table 50. Global Alpha Synuclein Sales by Region (2027-2032) & (K Units) Table 51. Global Alpha Synuclein Sales Market Share by Region (2027-2032) Table 52. Global Alpha Synuclein Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 53. Global Alpha Synuclein Sales Value by Region (2021-2026) & (US$ Million) Table 54. Global Alpha Synuclein Sales Value Share by Region (2021-2026) Table 55. Global Alpha Synuclein Sales Value by Region (2027-2032) & (US$ Million) Table 56. Global Alpha Synuclein Sales Value Share by Region (2027-2032) Table 57. Global Alpha Synuclein Market Average Price (US$/Unit) by Region (2021-2026) Table 58. Global Alpha Synuclein Market Average Price (US$/Unit) by Region (2027-2032) Table 59. Global Alpha Synuclein Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 60. Global Alpha Synuclein Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Alpha Synuclein Sales by Country (2021-2026) & (K Units) Table 62. Global Alpha Synuclein Sales Market Share by Country (2021-2026) Table 63. Global Alpha Synuclein Sales by Country (2027-2032) & (K Units) Table 64. Global Alpha Synuclein Sales Market Share by Country (2027-2032) Table 65. Global Alpha Synuclein Sales Value by Country (2021-2026) & (US$ Million) Table 66. Global Alpha Synuclein Sales Value Market Share by Country (2021-2026) Table 67. Global Alpha Synuclein Sales Value by Country (2027-2032) & (US$ Million) Table 68. Global Alpha Synuclein Sales Value Market Share by Country (2027-2032) Table 69. Biogen Inc Company Information Table 70. Biogen Inc Business Overview Table 71. Biogen Inc Alpha Synuclein Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Biogen Inc Alpha Synuclein Product Portfolio Table 73. Biogen Inc Recent Development Table 74. reMYND NV Company Information Table 75. reMYND NV Business Overview Table 76. reMYND NV Alpha Synuclein Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. reMYND NV Alpha Synuclein Product Portfolio Table 78. reMYND NV Recent Development Table 79. QR Pharma Inc Company Information Table 80. QR Pharma Inc Business Overview Table 81. QR Pharma Inc Alpha Synuclein Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. QR Pharma Inc Alpha Synuclein Product Portfolio Table 83. QR Pharma Inc Recent Development Table 84. Prothena Corp Plc Company Information Table 85. Prothena Corp Plc Business Overview Table 86. Prothena Corp Plc Alpha Synuclein Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Prothena Corp Plc Alpha Synuclein Product Portfolio Table 88. Prothena Corp Plc Recent Development Table 89. nLife Therapeutics SL Company Information Table 90. nLife Therapeutics SL Business Overview Table 91. nLife Therapeutics SL Alpha Synuclein Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. nLife Therapeutics SL Alpha Synuclein Product Portfolio Table 93. nLife Therapeutics SL Recent Development Table 94. Neuropore Therapies Inc Company Information Table 95. Neuropore Therapies Inc Business Overview Table 96. Neuropore Therapies Inc Alpha Synuclein Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Neuropore Therapies Inc Alpha Synuclein Product Portfolio Table 98. Neuropore Therapies Inc Recent Development Table 99. MedImmune LLC Company Information Table 100. MedImmune LLC Business Overview Table 101. MedImmune LLC Alpha Synuclein Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. MedImmune LLC Alpha Synuclein Product Portfolio Table 103. MedImmune LLC Recent Development Table 104. ICB International Inc Company Information Table 105. ICB International Inc Business Overview Table 106. ICB International Inc Alpha Synuclein Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. ICB International Inc Alpha Synuclein Product Portfolio Table 108. ICB International Inc Recent Development Table 109. H. Lundbeck A/S Company Information Table 110. H. Lundbeck A/S Business Overview Table 111. H. Lundbeck A/S Alpha Synuclein Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. H. Lundbeck A/S Alpha Synuclein Product Portfolio Table 113. H. Lundbeck A/S Recent Development Table 114. Genmab A/S Company Information Table 115. Genmab A/S Business Overview Table 116. Genmab A/S Alpha Synuclein Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Genmab A/S Alpha Synuclein Product Portfolio Table 118. Genmab A/S Recent Development Table 119. Evotec AG Company Information Table 120. Evotec AG Business Overview Table 121. Evotec AG Alpha Synuclein Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Evotec AG Alpha Synuclein Product Portfolio Table 123. Evotec AG Recent Development Table 124. BioArctic AB Company Information Table 125. BioArctic AB Business Overview Table 126. BioArctic AB Alpha Synuclein Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. BioArctic AB Alpha Synuclein Product Portfolio Table 128. BioArctic AB Recent Development Table 129. AFFiRiS AG Company Information Table 130. AFFiRiS AG Business Overview Table 131. AFFiRiS AG Alpha Synuclein Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. AFFiRiS AG Alpha Synuclein Product Portfolio Table 133. AFFiRiS AG Recent Development Table 134. AC Immune SA Company Information Table 135. AC Immune SA Business Overview Table 136. AC Immune SA Alpha Synuclein Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. AC Immune SA Alpha Synuclein Product Portfolio Table 138. AC Immune SA Recent Development Table 139. Key Raw Materials Table 140. Raw Materials Key Suppliers Table 141. Alpha Synuclein Distributors List Table 142. Alpha Synuclein Customers List Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources Table 146. Primary Sources List of Figures Figure 1. Alpha Synuclein Product Image Figure 2. Global Alpha Synuclein Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Alpha Synuclein Sales Value (2021-2032) & (US$ Million) Figure 4. Global Alpha Synuclein Sales (2021-2032) & (K Units) Figure 5. Global Alpha Synuclein Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Alpha Synuclein Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. DPC-003 Image Figure 10. BIIB-054 Image Figure 11. BAN-0805 Image Figure 12. AV-1950R Image Figure 13. AV-1947D Image Figure 14. Others Image Figure 15. Global Alpha Synuclein Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Alpha Synuclein Sales Volume Share 2021 VS 2025 VS 2032 Figure 17. Global Alpha Synuclein Sales Volume Share by Type (2021-2032) Figure 18. Global Alpha Synuclein Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Alpha Synuclein Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Alpha Synuclein Sales Value Share by Type (2021-2032) Figure 21. Multiple System Atrophy Image Figure 22. Lewy Body Dementia Image Figure 23. Neurodegenerateive Disease Image Figure 24. Others Image Figure 25. Global Alpha Synuclein Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global Alpha Synuclein Sales Volume Share 2021 VS 2025 VS 2032 Figure 27. Global Alpha Synuclein Sales Volume Share by Application (2021-2032) Figure 28. Global Alpha Synuclein Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Alpha Synuclein Sales Value Share 2021 VS 2025 VS 2032 Figure 30. Global Alpha Synuclein Sales Value Share by Application (2021-2032) Figure 31. Global Alpha Synuclein Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 32. Global Alpha Synuclein Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 33. Global Alpha Synuclein Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 34. Global Alpha Synuclein Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 35. North America Alpha Synuclein Sales Value (2021-2032) & (US$ Million) Figure 36. North America Alpha Synuclein Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Europe Alpha Synuclein Sales Value (2021-2032) & (US$ Million) Figure 38. Europe Alpha Synuclein Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Asia-Pacific Alpha Synuclein Sales Value (2021-2032) & (US$ Million) Figure 40. Asia-Pacific Alpha Synuclein Sales Value Share by Country (%), 2025 VS 2032 Figure 41. South America Alpha Synuclein Sales Value (2021-2032) & (US$ Million) Figure 42. South America Alpha Synuclein Sales Value Share by Country (%), 2025 VS 2032 Figure 43. Middle East & Africa Alpha Synuclein Sales Value (2021-2032) & (US$ Million) Figure 44. Middle East & Africa Alpha Synuclein Sales Value Share by Country (%), 2025 VS 2032 Figure 45. USA Alpha Synuclein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. USA Alpha Synuclein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. USA Alpha Synuclein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Canada Alpha Synuclein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Canada Alpha Synuclein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Canada Alpha Synuclein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Mexico Alpha Synuclein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Mexico Alpha Synuclein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Mexico Alpha Synuclein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Germany Alpha Synuclein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Germany Alpha Synuclein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Germany Alpha Synuclein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. France Alpha Synuclein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. France Alpha Synuclein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. France Alpha Synuclein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. U.K. Alpha Synuclein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. U.K. Alpha Synuclein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. U.K. Alpha Synuclein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Italy Alpha Synuclein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Italy Alpha Synuclein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Italy Alpha Synuclein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Spain Alpha Synuclein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Spain Alpha Synuclein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Spain Alpha Synuclein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Russia Alpha Synuclein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Russia Alpha Synuclein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Russia Alpha Synuclein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Netherlands Alpha Synuclein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Netherlands Alpha Synuclein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Netherlands Alpha Synuclein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Nordic Countries Alpha Synuclein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Nordic Countries Alpha Synuclein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Nordic Countries Alpha Synuclein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. China Alpha Synuclein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. China Alpha Synuclein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. China Alpha Synuclein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Japan Alpha Synuclein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Japan Alpha Synuclein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Japan Alpha Synuclein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. South Korea Alpha Synuclein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. South Korea Alpha Synuclein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. South Korea Alpha Synuclein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. India Alpha Synuclein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. India Alpha Synuclein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. India Alpha Synuclein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Australia Alpha Synuclein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Australia Alpha Synuclein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Australia Alpha Synuclein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Southeast Asia Alpha Synuclein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Southeast Asia Alpha Synuclein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Southeast Asia Alpha Synuclein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Brazil Alpha Synuclein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Brazil Alpha Synuclein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Brazil Alpha Synuclein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Argentina Alpha Synuclein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Argentina Alpha Synuclein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Argentina Alpha Synuclein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Chile Alpha Synuclein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Chile Alpha Synuclein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Chile Alpha Synuclein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Colombia Alpha Synuclein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Colombia Alpha Synuclein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Colombia Alpha Synuclein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Peru Alpha Synuclein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Peru Alpha Synuclein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Peru Alpha Synuclein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Alpha Synuclein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Saudi Arabia Alpha Synuclein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Saudi Arabia Alpha Synuclein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Israel Alpha Synuclein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Israel Arabia Alpha Synuclein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Israel Arabia Alpha Synuclein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. UAE Alpha Synuclein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. UAE Alpha Synuclein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. UAE Alpha Synuclein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Turkey Alpha Synuclein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Turkey Alpha Synuclein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Turkey Alpha Synuclein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Iran Alpha Synuclein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Iran Alpha Synuclein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Iran Alpha Synuclein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Egypt Alpha Synuclein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 127. Egypt Alpha Synuclein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 128. Egypt Alpha Synuclein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 129. Alpha Synuclein Value Chain Figure 130. Manufacturing Cost Structure Figure 131. Alpha Synuclein Sales Mode & Process Figure 132. Direct Comparison with Distribution Share Figure 133. Distributors Profiles Figure 134. Years Considered Figure 135. Research Process Figure 136. Key Executives Interviewed

Scope & coverage.

Types
  • DPC-003
  • BIIB-054
  • BAN-0805
  • AV-1950R
  • AV-1947D
  • Others
Applications
  • Multiple System Atrophy
  • Lewy Body Dementia
  • Neurodegenerateive Disease
  • Others
Companies covered
  • Biogen Inc
  • reMYND NV
  • QR Pharma Inc
  • Prothena Corp Plc
  • nLife Therapeutics SL
  • Neuropore Therapies Inc
  • MedImmune LLC
  • ICB International Inc
  • H. Lundbeck A/S
  • Genmab A/S
  • Evotec AG
  • BioArctic AB
  • AFFiRiS AG
  • AC Immune SA

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Alpha Synuclein Sales Value (2021-2032)
  4. 1.2.2 Global Alpha Synuclein Sales Volume (2021-2032)
  5. 1.2.3 Global Alpha Synuclein Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Alpha Synuclein Market Dynamics
  1. 2.1 Alpha Synuclein Industry Trends
  2. 2.2 Alpha Synuclein Industry Drivers
  3. 2.3 Alpha Synuclein Industry Opportunities and Challenges
  4. 2.4 Alpha Synuclein Industry Restraints
3 Alpha Synuclein Market by Company
  1. 3.1 Global Alpha Synuclein Company Revenue Ranking in 2025
  2. 3.2 Global Alpha Synuclein Revenue by Company (2021-2026)
  3. 3.3 Global Alpha Synuclein Sales Volume by Company (2021-2026)
  4. 3.4 Global Alpha Synuclein Average Price by Company (2021-2026)
  5. 3.5 Global Alpha Synuclein Company Ranking (2024-2026)
  6. 3.6 Global Alpha Synuclein Company Manufacturing Base and Headquarters
  7. 3.7 Global Alpha Synuclein Company Product Type and Application
  8. 3.8 Global Alpha Synuclein Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Alpha Synuclein Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Alpha Synuclein Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Alpha Synuclein Market by Type
  1. 4.1 Alpha Synuclein Type Introduction
  2. 4.1.1 DPC-003
  3. 4.1.2 BIIB-054
  4. 4.1.3 BAN-0805
  5. 4.1.4 AV-1950R
  6. 4.1.5 AV-1947D
  7. 4.1.6 Others
  8. 4.2 Global Alpha Synuclein Sales Volume by Type
  9. 4.2.1 Global Alpha Synuclein Sales Volume by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Alpha Synuclein Sales Volume by Type (2021-2032)
  11. 4.2.3 Global Alpha Synuclein Sales Volume Share by Type (2021-2032)
  12. 4.3 Global Alpha Synuclein Sales Value by Type
  13. 4.3.1 Global Alpha Synuclein Sales Value by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Alpha Synuclein Sales Value by Type (2021-2032)
  15. 4.3.3 Global Alpha Synuclein Sales Value Share by Type (2021-2032)
5 Alpha Synuclein Market by Application
  1. 5.1 Alpha Synuclein Application Introduction
  2. 5.1.1 Multiple System Atrophy
  3. 5.1.2 Lewy Body Dementia
  4. 5.1.3 Neurodegenerateive Disease
  5. 5.1.4 Others
  6. 5.2 Global Alpha Synuclein Sales Volume by Application
  7. 5.2.1 Global Alpha Synuclein Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Alpha Synuclein Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Alpha Synuclein Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Alpha Synuclein Sales Value by Application
  11. 5.3.1 Global Alpha Synuclein Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Alpha Synuclein Sales Value by Application (2021-2032)
  13. 5.3.3 Global Alpha Synuclein Sales Value Share by Application (2021-2032)
6 Alpha Synuclein Regional Sales and Value Analysis
  1. 6.1 Global Alpha Synuclein Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Alpha Synuclein Sales by Region (2021-2032)
  3. 6.2.1 Global Alpha Synuclein Sales by Region: 2021-2026
  4. 6.2.2 Global Alpha Synuclein Sales by Region (2027-2032)
  5. 6.3 Global Alpha Synuclein Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Alpha Synuclein Sales Value by Region (2021-2032)
  7. 6.4.1 Global Alpha Synuclein Sales Value by Region: 2021-2026
  8. 6.4.2 Global Alpha Synuclein Sales Value by Region (2027-2032)
  9. 6.5 Global Alpha Synuclein Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Alpha Synuclein Sales Value (2021-2032)
  12. 6.6.2 North America Alpha Synuclein Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Alpha Synuclein Sales Value (2021-2032)
  15. 6.7.2 Europe Alpha Synuclein Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Alpha Synuclein Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Alpha Synuclein Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Alpha Synuclein Sales Value (2021-2032)
  21. 6.9.2 South America Alpha Synuclein Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Alpha Synuclein Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Alpha Synuclein Sales Value Share by Country, 2025 VS 2032
7 Alpha Synuclein Country-level Sales and Value Analysis
  1. 7.1 Global Alpha Synuclein Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Alpha Synuclein Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Alpha Synuclein Sales by Country (2021-2032)
  4. 7.3.1 Global Alpha Synuclein Sales by Country (2021-2026)
  5. 7.3.2 Global Alpha Synuclein Sales by Country (2027-2032)
  6. 7.4 Global Alpha Synuclein Sales Value by Country (2021-2032)
  7. 7.4.1 Global Alpha Synuclein Sales Value by Country (2021-2026)
  8. 7.4.2 Global Alpha Synuclein Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Alpha Synuclein Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Alpha Synuclein Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Alpha Synuclein Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Alpha Synuclein Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Alpha Synuclein Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Alpha Synuclein Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Alpha Synuclein Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Alpha Synuclein Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Alpha Synuclein Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Alpha Synuclein Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Alpha Synuclein Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Alpha Synuclein Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Alpha Synuclein Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Alpha Synuclein Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Alpha Synuclein Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Alpha Synuclein Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Alpha Synuclein Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Alpha Synuclein Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Alpha Synuclein Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Alpha Synuclein Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Alpha Synuclein Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Alpha Synuclein Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Alpha Synuclein Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Alpha Synuclein Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Alpha Synuclein Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Alpha Synuclein Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Alpha Synuclein Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Alpha Synuclein Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Alpha Synuclein Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Alpha Synuclein Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Alpha Synuclein Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Alpha Synuclein Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Alpha Synuclein Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Alpha Synuclein Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Alpha Synuclein Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Alpha Synuclein Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Alpha Synuclein Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Alpha Synuclein Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Alpha Synuclein Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Alpha Synuclein Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Alpha Synuclein Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Alpha Synuclein Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Alpha Synuclein Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Alpha Synuclein Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Alpha Synuclein Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Alpha Synuclein Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Alpha Synuclein Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Alpha Synuclein Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Alpha Synuclein Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Alpha Synuclein Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Alpha Synuclein Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Alpha Synuclein Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Alpha Synuclein Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Alpha Synuclein Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Alpha Synuclein Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Alpha Synuclein Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Alpha Synuclein Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Alpha Synuclein Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Alpha Synuclein Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Alpha Synuclein Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Alpha Synuclein Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Alpha Synuclein Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Alpha Synuclein Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Alpha Synuclein Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Alpha Synuclein Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Alpha Synuclein Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Alpha Synuclein Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Alpha Synuclein Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Alpha Synuclein Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Alpha Synuclein Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Alpha Synuclein Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Alpha Synuclein Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Alpha Synuclein Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Alpha Synuclein Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Alpha Synuclein Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Alpha Synuclein Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Alpha Synuclein Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Alpha Synuclein Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Alpha Synuclein Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Alpha Synuclein Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Alpha Synuclein Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Alpha Synuclein Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Alpha Synuclein Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Alpha Synuclein Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Biogen Inc
  2. 8.1.1 Biogen Inc Company Information
  3. 8.1.2 Biogen Inc Business Overview
  4. 8.1.3 Biogen Inc Alpha Synuclein Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Biogen Inc Alpha Synuclein Product Portfolio
  6. 8.1.5 Biogen Inc Recent Developments
  7. 8.2 reMYND NV
  8. 8.2.1 reMYND NV Company Information
  9. 8.2.2 reMYND NV Business Overview
  10. 8.2.3 reMYND NV Alpha Synuclein Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 reMYND NV Alpha Synuclein Product Portfolio
  12. 8.2.5 reMYND NV Recent Developments
  13. 8.3 QR Pharma Inc
  14. 8.3.1 QR Pharma Inc Company Information
  15. 8.3.2 QR Pharma Inc Business Overview
  16. 8.3.3 QR Pharma Inc Alpha Synuclein Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 QR Pharma Inc Alpha Synuclein Product Portfolio
  18. 8.3.5 QR Pharma Inc Recent Developments
  19. 8.4 Prothena Corp Plc
  20. 8.4.1 Prothena Corp Plc Company Information
  21. 8.4.2 Prothena Corp Plc Business Overview
  22. 8.4.3 Prothena Corp Plc Alpha Synuclein Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Prothena Corp Plc Alpha Synuclein Product Portfolio
  24. 8.4.5 Prothena Corp Plc Recent Developments
  25. 8.5 nLife Therapeutics SL
  26. 8.5.1 nLife Therapeutics SL Company Information
  27. 8.5.2 nLife Therapeutics SL Business Overview
  28. 8.5.3 nLife Therapeutics SL Alpha Synuclein Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 nLife Therapeutics SL Alpha Synuclein Product Portfolio
  30. 8.5.5 nLife Therapeutics SL Recent Developments
  31. 8.6 Neuropore Therapies Inc
  32. 8.6.1 Neuropore Therapies Inc Company Information
  33. 8.6.2 Neuropore Therapies Inc Business Overview
  34. 8.6.3 Neuropore Therapies Inc Alpha Synuclein Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Neuropore Therapies Inc Alpha Synuclein Product Portfolio
  36. 8.6.5 Neuropore Therapies Inc Recent Developments
  37. 8.7 MedImmune LLC
  38. 8.7.1 MedImmune LLC Company Information
  39. 8.7.2 MedImmune LLC Business Overview
  40. 8.7.3 MedImmune LLC Alpha Synuclein Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 MedImmune LLC Alpha Synuclein Product Portfolio
  42. 8.7.5 MedImmune LLC Recent Developments
  43. 8.8 ICB International Inc
  44. 8.8.1 ICB International Inc Company Information
  45. 8.8.2 ICB International Inc Business Overview
  46. 8.8.3 ICB International Inc Alpha Synuclein Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 ICB International Inc Alpha Synuclein Product Portfolio
  48. 8.8.5 ICB International Inc Recent Developments
  49. 8.9 H. Lundbeck A/S
  50. 8.9.1 H. Lundbeck A/S Company Information
  51. 8.9.2 H. Lundbeck A/S Business Overview
  52. 8.9.3 H. Lundbeck A/S Alpha Synuclein Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 H. Lundbeck A/S Alpha Synuclein Product Portfolio
  54. 8.9.5 H. Lundbeck A/S Recent Developments
  55. 8.10 Genmab A/S
  56. 8.10.1 Genmab A/S Company Information
  57. 8.10.2 Genmab A/S Business Overview
  58. 8.10.3 Genmab A/S Alpha Synuclein Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Genmab A/S Alpha Synuclein Product Portfolio
  60. 8.10.5 Genmab A/S Recent Developments
  61. 8.11 Evotec AG
  62. 8.11.1 Evotec AG Company Information
  63. 8.11.2 Evotec AG Business Overview
  64. 8.11.3 Evotec AG Alpha Synuclein Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Evotec AG Alpha Synuclein Product Portfolio
  66. 8.11.5 Evotec AG Recent Developments
  67. 8.12 BioArctic AB
  68. 8.12.1 BioArctic AB Company Information
  69. 8.12.2 BioArctic AB Business Overview
  70. 8.12.3 BioArctic AB Alpha Synuclein Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 BioArctic AB Alpha Synuclein Product Portfolio
  72. 8.12.5 BioArctic AB Recent Developments
  73. 8.13 AFFiRiS AG
  74. 8.13.1 AFFiRiS AG Company Information
  75. 8.13.2 AFFiRiS AG Business Overview
  76. 8.13.3 AFFiRiS AG Alpha Synuclein Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 AFFiRiS AG Alpha Synuclein Product Portfolio
  78. 8.13.5 AFFiRiS AG Recent Developments
  79. 8.14 AC Immune SA
  80. 8.14.1 AC Immune SA Company Information
  81. 8.14.2 AC Immune SA Business Overview
  82. 8.14.3 AC Immune SA Alpha Synuclein Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 AC Immune SA Alpha Synuclein Product Portfolio
  84. 8.14.5 AC Immune SA Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Alpha Synuclein Value Chain Analysis
  2. 9.1.1 Alpha Synuclein Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Alpha Synuclein Sales Mode & Process
  6. 9.2 Alpha Synuclein Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Alpha Synuclein Distributors
  9. 9.2.3 Alpha Synuclein Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst